Navigation Links
Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
Date:4/29/2013

STATESVILLE, N.C., April 29, 2013 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that William A. Shumaker , Kewaunee's Chairman of the Board and Chief Executive Officer, will retire on June 30, 2013 after almost 20 years of service with the Company. Mr. Shumaker will remain as a non-executive Chairman of the Board. As part of a planned leadership succession process, the Board of Directors appointed David M. Rausch , current President and Chief Operating Officer, to succeed Mr. Shumaker and to become a member of its Board of Directors, both effective July 1, 2013.

Mr. Shumaker, 65, joined the Company in December 1993 as Vice President of Sales and Marketing, after holding various management positions with businesses in the laboratory furniture and appliance industries for 24 years. After serving in several executive positions with the Company, he was elected President in 1999 and held that position until March 2012 when he relinquished this title. He has served as Chief Executive Officer and a director of Kewaunee Scientific Corporation since 2000 and Chairman of the Board since 2010.

The Company's directors conveyed their sincere gratitude to Mr. Shumaker for his many years of dedication and service to the Company, strong leadership skills, and strategic vision. Under his leadership, the Company established itself as a global provider of laboratory furniture and equipment, as it expanded sales representation throughout Asia and the Middle East, and established a modern manufacturing facility in India to serve the local and Asian markets. The Company has experienced significant growth in sales and market share in recent years in both the domestic and international markets. Mr. Shumaker leaves the Company in an excellent position to continue its growth in the future.

Mr. Rausch, 54, joined Kewaunee in 1994 as Manager of Estimating. Afterwards, he served in numerous sales and marketing management positions before being elected Vice President of Construction Services in June 2007. In June 2011, he was elected Senior Vice President of Construction Services and General Manager of the Laminate Furniture Division. He has served as President and Chief Operating Officer since March 2012. He has more than 30 years of experience within the laboratory furniture industry.

Following a succession planning process lasting more than two years, the Board expressed its confidence in Mr. Rausch's ability to lead the Company, stating that his demonstrated leadership abilities and deep knowledge of the laboratory furniture industry make him an excellent choice to succeed Mr. Shumaker.

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin counters and sinks. Healthcare furniture products include laminate casework, storage systems, and related products for healthcare applications. Technical furniture products include column systems, slotted-post systems, pedestal systems, and stand-alone benches.

The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets. One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.

Contact:

D. Michael Parker


704/871-3290


'/>"/>
SOURCE Kewaunee Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Kewaunee Scientific Reports Improved Results for Third Quarter
2. Kewaunee Scientific Reports Record Sales for Second Quarter
3. Kewaunee Scientific Corporation Declares Quarterly Dividend
4. Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter
5. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
6. Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer
7. SkelRegen Welcomes Director of Scientific Affairs to Management Team
8. MDA Scientific Conference To Focus On Therapy Development For Neuromuscular Diseases
9. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
10. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
11. Igenica Appoints Thi-Sau Migone, Ph.D., as Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 4, 2016 Global ... pages, profiling 09 key companies and supported with ... and in-depth study on the current state of ... of the industry including definitions, classifications, applications and ... is provided for the international market including development ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... Ariz. , May 3, 2016  As a ... twice contracted rheumatic fever, which damaged his heart. He ... But by June 2013, Shepherd,s heart was giving ... from death. On June 20, 2013, the ... Total Artificial Heart (TAH-t). Like a heart transplant, the ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... ... Recognizing that lifestyle medicine is essential to health and healthcare, About.com ... MD, MPH, president of the American College of Lifestyle Medicine, as their first senior ... said Katz. “There is so much opportunity to add years to lives, and life ...
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare ... Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old model and reality ... breast cancer that occurs in the milk ducts, according to an interview with ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... support for knees, ankles, and elbows. Engineered with athletes in mind, OMNIFORCE ... manufacturing (opposed to ineffective circular knitting, common in the industry) produces premium ...
(Date:5/4/2016)... ... May 04, 2016 , ... With the stamp of ... the month of May as National Cancer Research Month. According to the American ... of cancer with predications of one in four Americans dying as a result. , ...
(Date:5/4/2016)... ... 04, 2016 , ... International Conference on Obesity and Chronic ... at Las Vegas. It aims to bring together academicians, scientists, dietitians, surgeons, physicians, ... across the globe; making the conference a perfect platform to share experience and ...
Breaking Medicine News(10 mins):